Mitsuya H - Search Results

1

COVID-19 in Japan: An update on national policy, research, clinical practice, and vaccination campaign.

Song P, Mitsuya H, Kokudo N. Song P, et al. Among authors: mitsuya h. Glob Health Med. 2022 Apr 30;4(2):64-66. doi: 10.35772/ghm.2022.01036. Glob Health Med. 2022. PMID: 35586762 Free PMC article.

2

Focusing on global health and medicine.

Mitsuya H, Kokudo N. Mitsuya H, et al. Glob Health Med. 2019 Oct 31;1(1):1-2. doi: 10.35772/ghm.2019.01005. Glob Health Med. 2019. PMID: 33330746 Free PMC article.

3

A novel HIV-1 protease inhibitor, GRL-044, has potent activity against various HIV-1s with an extremely high genetic barrier to the emergence of HIV-1 drug resistance.

Aoki M, Chang SB, Das D, Martyr C, Delino NS, Takamatsu Y, Ghosh AK, Mitsuya H. Aoki M, et al. Among authors: mitsuya h. Glob Health Med. 2019 Oct 31;1(1):36-48. doi: 10.35772/ghm.2019.01003. Glob Health Med. 2019. PMID: 33330753 Free PMC article.

4

Sustaining containment of COVID-19: global sharing for pandemic response.

Mitsuya H, Kokudo N. Mitsuya H, et al. Glob Health Med. 2020 Apr 30;2(2):53-55. doi: 10.35772/ghm.2020.01040. Glob Health Med. 2020. PMID: 33330776 Free PMC article.

5

Fight against COVID-19 but avoid disruption of services for other communicable diseases (CDs) and noncommunicable diseases (NCDs).

Mitsuya H. Mitsuya H. Glob Health Med. 2020 Dec 31;2(6):343-345. doi: 10.35772/ghm.2020.01111. Glob Health Med. 2020. PMID: 33409412 Free PMC article.

6

Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan.

Yamamoto S, Tanaka A, Kobayashi S, Oshiro Y, Ozeki M, Maeda K, Matsuda K, Miyo K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Yamamoto S, et al. Among authors: mitsuya h. Glob Health Med. 2021 Apr 30;3(2):90-94. doi: 10.35772/ghm.2021.01022. Glob Health Med. 2021. PMID: 33937571 Free PMC article.

7

Advances in Oncology in US and Japan: Focusing on Cancer and Infectious Diseases.

Nakano H, Miyamoto T, Janjigian YY, Mine S, Mitsuya H, Ueno NT, Sharon E, Sakai S, Timmer WC, Nakabo S, Ikeuchi T, Fujiwara S, Kinjo M, Inuzuka T, Kume H, Shirai K, Yamaguchi N, Takabe K, Takebe N. Nakano H, et al. Among authors: mitsuya h. World J Oncol. 2021 Dec;12(6):183-194. doi: 10.14740/wjon1422. Epub 2021 Dec 13. World J Oncol. 2021. PMID: 35059078 Free PMC article. Review.

8

Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination.

Okumura N, Saito S, Takamatsu Y, Takeuchi JS, Asai Y, Sanada M, Iwamoto N, Maeda K, Mitsuya H, Ohmagari N. Okumura N, et al. Among authors: mitsuya h. J Infect Chemother. 2022 Dec;28(12):1704-1706. doi: 10.1016/j.jiac.2022.08.026. Epub 2022 Sep 5. J Infect Chemother. 2022. PMID: 36067912 Free PMC article.

9

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.

Tanaka A, Yamamoto S, Miyo K, Mizoue T, Maeda K, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Tanaka A, et al. Among authors: mitsuya h. J Infect. 2021 Apr;82(4):e1-e3. doi: 10.1016/j.jinf.2021.01.010. Epub 2021 Jan 29. J Infect. 2021. PMID: 33524423 Free PMC article. No abstract available.

10

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.

Yamamoto S, Tanaka A, Oshiro Y, Ishii M, Ishiwari H, Konishi M, Matsuda K, Ozeki M, Miyo K, Maeda K, Mizoue T, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Yamamoto S, et al. Among authors: mitsuya h. J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.05.017. Epub 2021 May 25. J Infect. 2021. PMID: 34044036 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

710 results

Search Page